Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ITUS Corp (NASDAQ:ITUS)

3.15
Delayed Data
As of 3:59pm ET
 +0.02 / +0.64%
Today’s Change
1.88
Today|||52-Week Range
5.50
+4.65%
Year-to-Date
SECTOR
Electronic Technology
INDUSTRY
Computer Peripherals
MARKET CAP
$27.4M

Company Description

ITUS Corp. is a pharmaceutical company, through its subsidiary, Anixa Diagnostics Corp. develops non-invasive blood tests for the early detection of solid tumor based cancers. The company was founded by Denis A. Krusos on November 5, 1982 and is headquartered in Los Angeles, CA.

Contact Information

ITUS Corp.
12100 Wilshire Boulevard
Los Angeles California 90025
P:(310) 484-5200
Investor Relations:
(310) 484-5184

Employees

Shareholders

Individual stakeholders10.18%
Other institutional0.99%
Mutual fund holders0.62%

Top Executives

Robert Andrew BermanPresident, Chief Executive Officer & Director
Dean KrouchSecretary & Operations Director
Henry P. HermsChief Financial Officer & Vice President-Finance
John A. RoopSenior Vice President-Engineering
Anthony CampisiVice President-Engineering